<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nephrotoxicity in association with <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> therapy is well recognised </plain></SENT>
<SENT sid="1" pm="."><plain>In this patient the nephrotoxicity only became apparent after severe <z:hpo ids='HP_0001824'>weight loss</z:hpo> had occurred in association with <z:hpo ids='HP_0009806'>nephrogenic diabetes insipidus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient aged 26 with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> received resin coated <z:chebi fb="0" ids="6775">mesalazine</z:chebi> (<z:chebi fb="0" ids="6775">Asacol</z:chebi>) 1200 mg/day and lost 12 kg in weight over a four month period, only complaining of thirst towards the end of this period </plain></SENT>
</text></document>